[依那西普在类风湿关节炎继发淀粉样变性中的应用，两例报告]
[Use of etanercept in amyloidosis secondary to rheumatoid arthritis, a report of two cases].
作者信息
Macías Fernández Inmaculada, Fernández Rodríguez Antonia María, García Pérez Sergio
机构信息
Sección de Reumatología, Hospital Universitario Puerta Del Mar, Cádiz, España.
出版信息
Reumatol Clin. 2011 Nov-Dec;7(6):397-400. doi: 10.1016/j.reuma.2010.12.005. Epub 2011 Mar 21.
PMID:22078699
Abstract
Rheumatoid arthritis (RA) is one of the most common causes of AA amyloidosis. Most patients are asymptomatic and only when there are large deposits in certain organs, functional problems arise. We report two patients with amyloidosis secondary to RA, with renal and intestinal involvement, who responded to treatment with etanercept.
摘要
类风湿关节炎（RA）是继发性淀粉样变性病（AA）最常见的病因之一。大多数患者没有症状，只有当某些器官出现大量沉积物时，才会出现功能问题。我们报告了两名继发于RA的淀粉样变性病患者，有肾脏和肠道受累，他们对依那西普治疗有反应。
Zotero 插件